Radko Komers

Company: Travere Therapeutics
Job title: Executive Director, Global Lead of Clinical Development Nephrology
Seminars:
Update on Sparsentan Development in Rare Kidney Diseases 3:30 pm
Summarizing available information from ongoing clinical trials with sparsentan in patients with IgA nephropathy and FSGS Exploring data in parallel with supporting preclinical evidence Navigating next steps in clinical development and beyond orphan drug designationRead more
day: Day Two